Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 4/20 | 1.00 |
| ▸ | NPC1 | O15118 | 3/20 | 1.00 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 1.00 |
| ▸ | GLA | P06280 | 1/20 | 1.00 |
| ▸ | ATM | Q13315 | 1/20 | 1.00 |
| ▸ | NR1H4 | Q96RI1 | 4/20 | 0.66 |
| ▸ | PPARG | P37231 | 3/20 | 0.66 |
| ▸ | CA1 | P00915 | 1/20 | 0.62 |
| ▸ | CA2 | P00918 | 1/20 | 0.62 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.61 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.61 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | RECQL | P46063 | 1/20 | 0.59 |
| ▸ | PPARA | Q07869 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.57 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10143976 | 0.88 | NPC1 (0.78) | RAB9ANPC1L3MBTL1ALDH1A1GLA | |
| SCHEMBL7296261 | 0.88 | RAB9A (0.78) | RAB9ANPC1L3MBTL1ALDH1A1GLA | |
| SCHEMBL7294705 | 0.86 | MAPT (0.82) | RAB9ANPC1L3MBTL1ALDH1A1GLA | |
| SCHEMBL2343610 | 0.86 | NPC1 (0.74) | RAB9ANPC1L3MBTL1ALDH1A1GLA | |
| SCHEMBL15149589 | 0.86 | NPC1 (0.74) | RAB9ANPC1L3MBTL1ALDH1A1GLA | |
| SCHEMBL29661130 | 0.86 | NPC1 (0.74) | RAB9ANPC1L3MBTL1ALDH1A1GLA | |
| SCHEMBL5223315 | 0.85 | RAB9A (0.73) | RAB9ANPC1L3MBTL1ALDH1A1GLA | |
| SCHEMBL13881198 | 0.83 | RAB9A (1.00) | RAB9ANPC1L3MBTL1ALDH1A1GLA | |
| SCHEMBL29960964 | 0.83 | NPC1 (0.74) | RAB9ANPC1L3MBTL1ALDH1A1GLA | |
| SCHEMBL3794850 | 0.83 | NPC1 (0.74) | RAB9ANPC1L3MBTL1ALDH1A1GLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230303570-A1 | KINASE INHIBITORS AND USES THEREOF | ABM THERAPEUTICS CORP (US) | 2023-09-28 | — | — | US | disclosed |
| US-20230303570-A1 | KINASE INHIBITORS AND USES THEREOF | ABM THERAPEUTICS CORP (US) | 2023-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230303570-A1 | KINASE INHIBITORS AND USES THEREOF | ERBB2, ERBB3, ERBB4 | RAB9A 1217/4885NPC1 4713/4885L3MBTL1 2805/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.